<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Sernova Corp — News on 6ix</title>
    <link>https://6ix.com/company/sernova-corp</link>
    <description>Latest news and press releases for Sernova Corp on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 23 Apr 2026 20:15:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/sernova-corp" rel="self" type="application/rss+xml" />
    <item>
      <title>Sernova Biotherapeutics Announces Closing of Recently Approved Financings</title>
      <link>https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-announces-closing-of-recently-approved-financings</link>
      <guid isPermaLink="true">https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-announces-closing-of-recently-approved-financings</guid>
      <pubDate>Thu, 23 Apr 2026 20:15:00 GMT</pubDate>
      <description>Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - April 23, 2026) - Sernova Biotherap...</description>
    </item>
    <item>
      <title>Sernova Biotherapeutics Announces Affirmative Voting Results from 2026 Annual General Meeting of Shareholders</title>
      <link>https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-announces-affirmative-voting-results-from-2026-annual-general-meeting-of-shareholders</link>
      <guid isPermaLink="true">https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-announces-affirmative-voting-results-from-2026-annual-general-meeting-of-shareholders</guid>
      <pubDate>Thu, 09 Apr 2026 11:00:00 GMT</pubDate>
      <description>Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - April 9, 2026) - Sernova Biotherape...</description>
    </item>
    <item>
      <title>Sernova Biotherapeutics Announces Close of Non-Brokered Private Placement Financing</title>
      <link>https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-announces-close-of-non-brokered-private-placement-financing</link>
      <guid isPermaLink="true">https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-announces-close-of-non-brokered-private-placement-financing</guid>
      <pubDate>Tue, 24 Mar 2026 11:00:00 GMT</pubDate>
      <description>Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - March 24, 2026) - Sernova Biotherap...</description>
    </item>
    <item>
      <title>Sernova Biotherapeutics Strengthens Balance Sheet with $7.1 Million in Financings Plus Net Retirement of a Cumulative $17 Million of Debt Subject to Shareholder Approval</title>
      <link>https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-strengthens-balance-sheet-with-dollar71-million-in-financings-plus-net-retirement-of-a-cumulative-dollar17-million-of-debt-subject-to-shareholder-approval-7</link>
      <guid isPermaLink="true">https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-strengthens-balance-sheet-with-dollar71-million-in-financings-plus-net-retirement-of-a-cumulative-dollar17-million-of-debt-subject-to-shareholder-approval-7</guid>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <description>Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - March 4, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSHO) (&quot;Sernova&quot; or the &quot;Company&quot;), a leading regenerative medicine company focused on developing its Cell Pouch Bio-hybrid Organ as a functional cure for type 1 diabetes (T1D), today announced financing transactions totaling $7.1 million, significantly strengthening the Company&apos;s balance sheet and financial position.The transactions include:$1.6 million equity...</description>
    </item>
    <item>
      <title>Sernova Biotherapeutics Announces Warrant Amendments</title>
      <link>https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-announces-warrant-amendments</link>
      <guid isPermaLink="true">https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-announces-warrant-amendments</guid>
      <pubDate>Fri, 20 Feb 2026 12:00:00 GMT</pubDate>
      <description>Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - February 20, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH0) (&quot;the Company&quot;), a leading regenerative medicine company focused on developing its Cell Pouch Bio-hybrid Organ as a functional cure for type 1 diabetes (T1D), today announced that, subject to approval from the TSX, the Company intends to amend some of its outstanding warrants.The Company issued 20,852,100 warrants pursuant to a private placement unit...</description>
    </item>
    <item>
      <title>From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes</title>
      <link>https://6ix.com/company/sernova-corp/news/from-insulin-injections-to-functional-cures-regenerative-medicine-reshapes-diabetes</link>
      <guid isPermaLink="true">https://6ix.com/company/sernova-corp/news/from-insulin-injections-to-functional-cures-regenerative-medicine-reshapes-diabetes</guid>
      <pubDate>Tue, 16 Dec 2025 17:00:04 GMT</pubDate>
      <description>VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) --     USA News Group       News Comm...</description>
    </item>
    <item>
      <title>Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts</title>
      <link>https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-closes-first-tranche-of-a-private-placement-of-equity-financing-to-support-ongoing-clinical-efforts</link>
      <guid isPermaLink="true">https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-closes-first-tranche-of-a-private-placement-of-equity-financing-to-support-ongoing-clinical-efforts</guid>
      <pubDate>Thu, 13 Nov 2025 12:00:00 GMT</pubDate>
      <description>Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biothe...</description>
    </item>
    <item>
      <title>Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang</title>
      <link>https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-announces-dollar13-million-debt-to-equity-conversion-eliminating-significant-financing-overhang</link>
      <guid isPermaLink="true">https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-announces-dollar13-million-debt-to-equity-conversion-eliminating-significant-financing-overhang</guid>
      <pubDate>Wed, 01 Oct 2025 11:00:00 GMT</pubDate>
      <description>Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biothera...</description>
    </item>
    <item>
      <title>Sernova Biotherapeutics Appoints John L. Brooks III, Former Chair and CEO of Joslin Diabetes Research Center, as Chair of the Board of Directors</title>
      <link>https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-appoints-john-l-brooks-iii-former-chair-and-ceo-of-joslin-diabetes-research-center-as-chair-of-the-board-of-directors</link>
      <guid isPermaLink="true">https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-appoints-john-l-brooks-iii-former-chair-and-ceo-of-joslin-diabetes-research-center-as-chair-of-the-board-of-directors</guid>
      <pubDate>Tue, 23 Sep 2025 12:00:00 GMT</pubDate>
      <description>(TheNewswire)       TORONTO and BOSTON - September 22, 2025 -     The     Newswire &amp;#x2014; Serno...</description>
    </item>
    <item>
      <title>Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference</title>
      <link>https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-to-participate-in-the-hc-wainwright-27th-annual-global-investor-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-to-participate-in-the-hc-wainwright-27th-annual-global-investor-conference</guid>
      <pubDate>Mon, 08 Sep 2025 13:45:00 GMT</pubDate>
      <description>(TheNewswire)       London, Ontario &amp;#x2013;     TheNewswire -     September     8     , 2025 - S...</description>
    </item>
    <item>
      <title>Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes</title>
      <link>https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-announces-collaboration-with-eledon-pharmaceuticals-to-advance-a-potential-functional-cure-for-type-1-diabetes</link>
      <guid isPermaLink="true">https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-announces-collaboration-with-eledon-pharmaceuticals-to-advance-a-potential-functional-cure-for-type-1-diabetes</guid>
      <pubDate>Wed, 09 Jul 2025 12:30:00 GMT</pubDate>
      <description>LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics (&amp;#x201C;Sernova&amp;#x201...</description>
    </item>
    <item>
      <title>Sernova Appoints Jonathan Rigby as Interim Chair</title>
      <link>https://6ix.com/company/sernova-corp/news/sernova-appoints-jonathan-rigby-as-interim-chair</link>
      <guid isPermaLink="true">https://6ix.com/company/sernova-corp/news/sernova-appoints-jonathan-rigby-as-interim-chair</guid>
      <pubDate>Mon, 02 Jun 2025 20:15:00 GMT</pubDate>
      <description>LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA)...</description>
    </item>
    <item>
      <title>Chair of Sernova Biotherapeutics Resigns</title>
      <link>https://6ix.com/company/sernova-corp/news/chair-of-sernova-biotherapeutics-resigns</link>
      <guid isPermaLink="true">https://6ix.com/company/sernova-corp/news/chair-of-sernova-biotherapeutics-resigns</guid>
      <pubDate>Mon, 26 May 2025 04:00:00 GMT</pubDate>
      <description>LONDON, Ontario and BOSTON, May 26, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) ...</description>
    </item>
    <item>
      <title>Sernova Biotherapeutics Appoints World-Class Clinical Advisory Board to Support Development of Cell Pouch Bio-hybrid Organ as Functional Cure for Type 1 Diabetes</title>
      <link>https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-appoints-world-class-clinical-advisory-board-to-support-development-of-cell-pouch-bio-hybrid-organ-as-functional-cure-for-type-1-diabetes</link>
      <guid isPermaLink="true">https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-appoints-world-class-clinical-advisory-board-to-support-development-of-cell-pouch-bio-hybrid-organ-as-functional-cure-for-type-1-diabetes</guid>
      <pubDate>Thu, 22 May 2025 11:00:00 GMT</pubDate>
      <description>LONDON, Ontario and BOSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) ...</description>
    </item>
    <item>
      <title>Sernova Biotherapeutics Provides Positive Interim Data from Ongoing Phase 1/2 Clinical Trial of Cell Pouch Bio-hybrid Organ in Patients Living with Type 1 Diabetes</title>
      <link>https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-provides-positive-interim-data-from-ongoing-phase-12-clinical-trial-of-cell-pouch-bio-hybrid-organ-in-patients-living-with-type-1-diabetes</link>
      <guid isPermaLink="true">https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-provides-positive-interim-data-from-ongoing-phase-12-clinical-trial-of-cell-pouch-bio-hybrid-organ-in-patients-living-with-type-1-diabetes</guid>
      <pubDate>Wed, 14 May 2025 11:00:00 GMT</pubDate>
      <description>Clinical Study on Track to Meet its Primary and Secondary Endpoints         Data Demonstrate That...</description>
    </item>
    <item>
      <title>Sernova Biotherapeutics Secures $4 Million Loan to Further Advance its Clinical Development Plans</title>
      <link>https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-secures-dollar4-million-loan-to-further-advance-its-clinical-development-plans</link>
      <guid isPermaLink="true">https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-secures-dollar4-million-loan-to-further-advance-its-clinical-development-plans</guid>
      <pubDate>Thu, 17 Apr 2025 12:00:00 GMT</pubDate>
      <description>LONDON, Ontario and BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA...</description>
    </item>
    <item>
      <title>Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell &amp; Gene Meeting on the Med</title>
      <link>https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-cell-pouch-bio-hybrid-organ-to-be-highlighted-at-cell-and-gene-meeting-on-the-med</link>
      <guid isPermaLink="true">https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-cell-pouch-bio-hybrid-organ-to-be-highlighted-at-cell-and-gene-meeting-on-the-med</guid>
      <pubDate>Tue, 15 Apr 2025 20:05:48 GMT</pubDate>
      <description>LONDON, Ontario and BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA...</description>
    </item>
    <item>
      <title>Sernova Biotherapeutics Provides Update on Phase 1/2 Clinical Trial of Cell Pouch(TM) Bio-Hybrid Organ for Treatment of Type 1 Diabetes</title>
      <link>https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-provides-update-on-phase-12-clinical-trial-of-cell-pouchtm-bio-hybrid-organ-for-treatment-of-type-1-diabetes</link>
      <guid isPermaLink="true">https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-provides-update-on-phase-12-clinical-trial-of-cell-pouchtm-bio-hybrid-organ-for-treatment-of-type-1-diabetes</guid>
      <pubDate>Tue, 01 Apr 2025 12:00:00 GMT</pubDate>
      <description>DSMB supports advancement for Sernova&amp;#x2019;s clinical trial         Study is on track to meet k...</description>
    </item>
    <item>
      <title>Sernova Biotherapeutics Provides Update on Phase 1/2 Clinical Trial of Cell Pouch™ Bio-Hybrid Organ for Treatment of Type 1 Diabetes</title>
      <link>https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-provides-phase-1-120000717</link>
      <guid isPermaLink="true">https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-provides-phase-1-120000717</guid>
      <pubDate>Tue, 01 Apr 2025 12:00:00 GMT</pubDate>
      <description>DSMB supports advancement for Sernova’s clinical trial Study is on track to meet key clinical trial endpoints LONDON, Ontario and BOSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing it’s Cell Pouch Bio-hybrid Organ as a functional cure for type 1 diabetes (T1D), today provided an update on its ongoing clinical trial in patients with T1D. Yesterday, on March 31, the Data and S</description>
    </item>
    <item>
      <title>Sernova Biotherapeutics Appoints Pericles Calias, Ph.D. as Chief Development Officer and Head of R&amp;D</title>
      <link>https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-appoints-pericles-calias-phd-as-chief-development-officer-and-head-of-randd</link>
      <guid isPermaLink="true">https://6ix.com/company/sernova-corp/news/sernova-biotherapeutics-appoints-pericles-calias-phd-as-chief-development-officer-and-head-of-randd</guid>
      <pubDate>Mon, 10 Mar 2025 12:00:00 GMT</pubDate>
      <description>LONDON, Ontario and BOSTON, March 10, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA...</description>
    </item>
  </channel>
</rss>